Search Results - brian+pollack

2 Results Sort By:
DHAA and Derivatives for Treatment of BRAF-V600E-Positive Cancer
Application Hypolipidemic dehydroacetic acid (DHAA) treatment to prevent growth of BRAF V600E positive tumors. Key Benefits Treatment with slows BRAF V600E-positive tumor growth. Repurposed compound may speed FDA approval. May be used in combination with other therapies. Market Summary Up to 50% of melanoma cases harbor the BRAF V600E mutation,...
Published: 9/26/2024   |   Inventor(s): Jing Chen, Jack Arbiser, Brian Pollack, Siyuan Xia
Keywords(s): Enzyme/Protein, Oncology, Repurposed Drug
Category(s): TechPub Algolia > Therapeutics
Repurposed Kinase Inhibitors as Vaccine Adjuvants
Application Repurposed, small molecule kinase inhibitors, such as epidermal growth factor receptor (EGFR) inhibitors, as topical vaccine adjuvants. Key Benefits Improves immune response and efficacy of vaccines and vaccine candidates. Employs compounds that are already approved for human use. Market Summary In order to create long lasting protection...
Published: 10/17/2024   |   Inventor(s): Brian Pollack, Richard Compans, Joanna Pulit-Penaloza, Ioanna Skountzou
Keywords(s): Immunology/Inflammation, Microbiology/Infectious Diseases, Repurposed Drug, Small Molecule
Category(s): TechPub Algolia > Therapeutics, TechPub Algolia > Vaccines